New Patterns of Innovation: Integrated Models of Biopharma

in Alumni, Health Sector, HSMP
November 15th, 2011

An Event from the Fall Alumni Association Speakers Program

L to R: Mike Nohaile, Matt McManus & Patrick F. Terry

L to R: Mike Nohaile, Matt McManus & Patrick F. Terry

In November 2011, the Health Sector Management Program inaugurated a fall speaker event to complement the spring one held for the past five years.  “New Patterns of Innovation” presented a dynamic panel that addressed the rapidly growing and shifting areas of diagnostics and linked therapeutics often labeled “personalized medicine.” After initial remarks the participants engaged in a lively and far-ranging discussion fed by questions and comments from the audience, and an intense discussion continued during the following reception.

Moderator: Jeff Elton, Lecturer, Health Sector Management Program, Boston University School of Management; CEO, the KEW Group

Distinguished Panel:

  • Mike Nohaile, Ph.D., Global Head of Molecular Diagnostics, Novartis
  • Patrick F. Terry, Principal, Pricing and Market Access Practice, Scientia Advisors LLC
  • Matt McManus, MD, PhD, MBA, President and CEO, PrimeraDx

Core sponsors were the Health Sector Management Alumni Association and Health Sector Management Program.  Cosponsors included the Schools of Medicine, Public Health, Law, and Engineering, as well as the Health Services Management and Bio Business Organization student organizations at Boston University.